PartitionBio™ awarded grant to exploit its novel biologics shuttle platform for therapeutic nucleic acids delivery

CAMBRIDGE, England, June 17, 2024 /PRNewswire/ — PartitionBio™ received a grant from the Bill & Melinda Gates Foundation to utilise its proprietary biocondensate-based macromolecule delivery platform for the transfection of cells with nucleic acids. The purpose of the project is to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks